Publicaciones (233) Publicaciones de CARLOS JUAN LUMBRERAS BERMEJO

2024

  1. Assessing the impact of long-term inhaled corticosteroid therapy on patients with COVID-19 and coexisting chronic lung disease: A multicenter retrospective cohort study

    Canadian Journal of Respiratory Therapy, Vol. 60, pp. 86-94

  2. Assessment of risk-adjusted mortality ratio (RAMR) in bloodstream infections using all-patient refined diagnosis-related groups (APR-DRGs)

    The Journal of antimicrobial chemotherapy, Vol. 79, Núm. 5, pp. 1019-1022

  3. Corrigendum: Immune dysregulation is an important factor in the underlying complications in Influenza infection. ApoH, IL-8 and IL-15 as markers of prognosis(Front. Immunol., (2024), 15, (1443096), 10.3389/fimmu.2024.1443096)

    Frontiers in Immunology

  4. Efficacy and safety of a preventive strategy against tuberculosis in liver transplantation recipients including the treatment of latent infection with moxifloxacin

    Transplant Infectious Disease

  5. Enhancing screening adherence for strongyloides infection in latinx inpatients with COVID-19: a local protocol implementation study

    Pathogens and Global Health, Vol. 118, Núm. 3, pp. 232-240

  6. Immune dysregulation is an important factor in the underlying complications in Influenza infection. ApoH, IL-8 and IL-15 as markers of prognosis

    Frontiers in Immunology, Vol. 15

  7. Impact of a Hospitalist Co-Management Program on Medical Complications and Length of Stay in Neurosurgical Patients

    Joint Commission Journal on Quality and Patient Safety, Vol. 50, Núm. 5, pp. 318-325

  8. Is Antiviral Treatment with Remdesivir at the Acute Phase of SARS-CoV-2 Infection Effective for Decreasing the Risk of Long-Lasting Post-COVID Symptoms?

    Viruses, Vol. 16, Núm. 6

  9. Long-term neurological symptoms after acute COVID-19 illness requiring hospitalization in adult patients: insights from the ISARIC-COVID-19 follow-up study

    Journal of Neurology

  10. Optimising Clinical Epidemiology in Disease Outbreaks: Analysis of ISARIC-WHO COVID-19 Case Report Form Utilisation

    Epidemiologia, Vol. 5, Núm. 3, pp. 557-580

  11. Presence of SARS-CoV-2 RNA in COVID-19 survivors with post-COVID symptoms 2 years after hospitalization: The VIPER study

    Journal of Medical Virology, Vol. 96, Núm. 5

2023

  1. Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19

    Kidney International Reports, Vol. 8, Núm. 8, pp. 1514-1530

  2. Bacteremia in Patients with Solid Organ Cancer: Insights into Epidemiology and Antibiotic Consumption

    Cancers, Vol. 15, Núm. 23

  3. COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study

    Cancers, Vol. 15, Núm. 5

  4. COVID-19 vaccines reduce mortality in hospitalized patients with oxygen requirements: Differences between vaccine subtypes. A multicontinental cohort study

    Journal of Medical Virology, Vol. 95, Núm. 5

  5. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19

    International Journal of Epidemiology, Vol. 52, Núm. 2, pp. 355-376

  6. Clinical outcomes by supplemental oxygen use in remdesivir-treated, hospitalised adults with COVID-19

    Infectious Diseases Now, Vol. 53, Núm. 7

  7. Disparities between Latinx migrants and Spanish natives in COVID-19 outcome in Madrid

    Pathogens and Global Health, Vol. 117, Núm. 6, pp. 590-595

  8. Impact of days elapsed from the onset of symptoms to hospitalization in COVID-19 in-hospital mortality: Time matters

    Revista Clinica Espanola, Vol. 223, Núm. 5, pp. 281-297

  9. Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry

    Scientific Reports, Vol. 13, Núm. 1